Clinical trials
Observational Graves Ophthalmopathy trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Recruiting | 8 |
| Unknown status | 7 |
| Not yet recruiting | 3 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Pisa | 6 |
| Shanghai Changzheng Hospital | 4 |
| Medical University of Warsaw | 3 |
| Medical University of Sofia | 2 |
| National Taiwan University Hospital | 2 |
| Sun Yat-sen University | 2 |
| THYROSCOPE INC. | 2 |
| University of Sao Paulo | 2 |
| Ameera Gamal Abdelhameed | 1 |
| Amgen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Graves Ophthalmopathy | 45 |
| Graves Disease | 14 |
| Heart Failure | 2 |
| Hypertension | 2 |
| Thyroid Diseases | 2 |
| Asthma | 1 |
| Autoimmune Diseases | 1 |
| Diplopia | 1 |
| Eye Diseases | 1 |
| Hypercholesterolemia | 1 |
Trials
Showing 76 to 45 of 45. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.